![]() |
市场调查报告书
商品编码
1625196
2030 年几丁聚醣市场预测:按来源、形式、等级、应用和地区进行的全球分析Chitosan Market Forecasts to 2030 - Global Analysis By Source (Crustaceans, Shrimp, Crab, Krill, Prawn, Squid, Lobster, and Fungi), Form, Grade, Application and By Geography |
根据 Stratistics MRC 的数据,2024 年全球几丁聚醣市场规模为 158.9 亿美元,预测期内复合年增长率为 22.3%,到 2030 年将达到 532 亿美元。
几丁聚醣是一种源自甲壳素的天然生物聚合物,甲壳素存在于虾和蟹等甲壳类动物的壳中。它是一种白色、无味、生物分解性的物质,常用于食品、医药、农业和化妆品等多种行业。几丁聚醣因其作为脂肪粘合剂、抗菌剂和天然防腐剂的能力而受到重视。由于其生物相容性,它广泛应用于创伤治疗和药物传输系统等医疗应用。
根据国家渔业发展委员会估计,2020年印度鱼类总产量预计为1,260万吨,其中近65%来自内陆部门,约50%来自水产养殖,约占6.3%。
越来越多地在食品和饮料行业中使用
几丁聚醣被誉为天然防腐剂,有助于延长保质期并保持食品新鲜,而无需使用合成化学物质。此外,它还可以作为低热量、无脂肪食品的脂肪替代品,满足消费者对更健康选择日益增长的需求。此外,几丁聚醣也用于机能性食品和营养补充剂,因为它能够结合脂肪并有助于体重管理。在消费者对天然和永续原料的偏好以及对健康和保健日益关注的推动下,几丁聚醣在食品包装和配方中的使用正在急剧发展。
生产成本高
从甲壳动物壳中提取几丁聚醣需要经过海水淡化、去乙酰和精製等复杂步骤,这增加了生产成本。此外,它需要专门的设备和技术来确保品质和一致性,这会增加成本。它还依赖虾壳和蟹壳等原料,这可能会给供应链带来挑战并推高价格。与合成替代品相比,这些高生产成本使得几丁聚醣产品价格昂贵,并限制了市场渗透,特别是在食品、包装和药品等成本敏感的应用中。
製药应用的增加
几丁聚醣由于其生物相容性、生物分解性和无毒性而越来越多地应用于製药行业。它在药物传递系统中发挥着重要作用,特别是在控制释放製剂中,有助于提高药物的生物有效性。此外,几丁聚醣可促进组织再生并具有抗菌特性,使其可用于创伤治疗产品。它还与脂肪结合併降低胆固醇,使其成为体重管理补充剂的关键成分。随着医学领域对天然、有效和永续解决方案的需求不断增加,几丁聚醣的多功能性正在扩大其在该领域的应用。
缺乏消费者意识
消费者缺乏对几丁聚醣用途和益处的了解是该行业的主要障碍。儘管几丁聚醣在食品、药物和农业等领域已广泛应用,但许多消费者仍担心其降低胆固醇、帮助减肥以及作为天然防腐剂的潜力,并不清楚其对健康的益处。这种无知限制了它的采用,特别是在开发中国家,消费者可能不知道它在机能性食品和营养保健品中的应用。为了增加市场占有率并推动成长,有必要让客户了解几丁聚醣的优点,包括其环境效益和对各种应用的适应性。
COVID-19 的影响
COVID-19 的爆发对几丁聚醣市场产生了各种影响。一方面,全球供应链中断影响了原材料的供应,导致生产延误和成本上升。另一方面,大流行期间人们对健康和保健的兴趣增加,增加了对几丁聚醣等天然成分的需求,特别是在营养补充剂和增强免疫力的产品中。此外,几丁聚醣在创伤治疗和药物传输等健康相关应用中的使用正在增加,其抗菌特性也增加了其需求。整体而言,这场大流行凸显了永续自然解决方案的重要性,长远来看有利于市场。
预计食品级细分市场在预测期内将是最大的
由于其天然、安全和多功能的特性,食品级市场预计是最大的市场。随着消费者健康意识的增强,食品级几丁聚醣越来越多地用作脂肪替代品、防腐剂和营养补充剂,特别是在减重产品中。其结合脂肪和降低胆固醇水平的能力进一步增加了几丁聚醣在机能性食品中的受欢迎程度。此外,食品加工中对天然和永续原料的日益偏好正在支持全球食品产业越来越多地采用食品级几丁聚醣。
预计农业部门在预测期内复合年增长率最高
由于农业具有天然生物杀虫、促进植物生长和土壤肥沃的特性,预计在预测期内复合年增长率最高。几丁聚醣用于保护作物免受真菌疾病、提高作物产量并刺激植物生长,使其成为化学农药的环保替代品。随着永续农业实践的发展和环境法规的收紧,几丁聚醣在有机农业和害虫防治中的作用变得越来越重要。由于几丁聚醣具有高度生物分解性和安全性,因此受到具有环保意识的农民的青睐,并越来越多地应用于农业领域。
由于食品、医药和农业领域对天然和永续产品的需求不断增长,预计亚太地区在预测期内将占据最大的市场占有率。该地区渔业发达,是甲壳素的稳定来源,甲壳素是生产几丁聚醣的主要原料。人们对体重管理和降低胆固醇等健康益处的认识不断提高,也推动了市场的成长。此外,对生态友善有机农业方法的日益关注以及支持永续农业投入的政府法规也推动了该地区几丁聚醣的采用。
预计北美地区在预测期内的复合年增长率最高。几丁聚醣因其降低胆固醇和脂肪结合特性而广泛用于体重管理补充剂、机能性食品和药品。此外,对环境永续性的日益关注以及向环保包装和农业实践的转变正在推动几丁聚醣的日益普及。北美市场也受惠于蓬勃的研发活动,有助于几丁聚醣在食品加工和生物医学等各行业的创新应用。
根据 Stratistics MRC 的数据,2024 年全球几丁聚醣市场规模为 158.9 亿美元,预测期内复合年增长率为 22.3%,到 2030 年将达到 532 亿美元。几丁聚醣是一种源自甲壳素的天然生物聚合物,甲壳素存在于虾和蟹等甲壳类动物的壳中。它是一种白色、无味、生物分解性的物质,常用于食品、医药、农业和化妆品等多种行业。几丁聚醣因其作为脂肪粘合剂、抗菌剂和天然防腐剂的能力而受到重视。由于其生物相容性,它广泛应用于创伤治疗和药物传输系统等医疗应用。
根据国家渔业发展委员会估计,2020年印度鱼类总产量预计为1,260万吨,其中近65%来自内陆部门,约50%来自水产养殖,约占6.3%。
越来越多地在食品和饮料行业中使用
几丁聚醣被誉为天然防腐剂,有助于延长保质期并保持食品新鲜,而无需使用合成化学物质。此外,它还可作为低热量、无脂肪食品的脂肪替代品,满足消费者对更健康选择日益增长的需求。此外,几丁聚醣也用于机能性食品和营养补充剂,因为它能够结合脂肪并有助于体重管理。由于消费者对天然和永续原料的偏好以及对健康和保健的日益关注,几丁聚醣在食品包装和配方中的使用正在急剧发展。
生产成本高
从甲壳动物壳中提取几丁聚醣需要海水淡化、去乙酰和精製等复杂步骤,增加了生产成本。此外,它需要专门的设备和技术来确保品质和一致性,这会增加成本。它还依赖虾壳和蟹壳等原料,这可能会给供应链带来挑战并推高价格。与合成替代品相比,这些高生产成本使得几丁聚醣产品价格昂贵,并限制了市场渗透,特别是在食品、包装和药品等成本敏感的应用中。
製药应用的增加
几丁聚醣由于其生物相容性、生物分解性和无毒性而越来越多地应用于製药行业。它在药物传递系统中发挥着重要作用,特别是在控制释放製剂中,有助于提高药物的生物有效性。此外,几丁聚醣可促进组织再生并具有抗菌特性,使其可用于创伤治疗产品。它还与脂肪结合併降低胆固醇,使其成为体重管理补充剂的关键成分。随着医学领域对天然、有效和永续解决方案的需求不断增加,几丁聚醣的多功能性正在扩大其在该领域的应用。
缺乏消费者意识
消费者缺乏对几丁聚醣用途和益处的了解是该行业的主要障碍。儘管几丁聚醣在食品、医药和农业等领域中广泛应用,但许多消费者仍然对其潜力持怀疑态度,包括降低胆固醇、帮助人们减肥以及作为天然防腐剂,但我不知道它的健康状况。好处。这种无知限制了它的采用,特别是在开发中国家,消费者可能不知道它在机能性食品和营养保健品中的应用。为了增加市场占有率并推动成长,有必要让客户了解几丁聚醣的优点,包括其环境效益和对各种应用的适应性。
COVID-19 的影响
COVID-19 的爆发对几丁聚醣市场产生了各种影响。一方面,全球供应链中断影响了原材料的供应,导致生产延误和成本上升。另一方面,大流行期间人们对健康和保健的兴趣增加,增加了对几丁聚醣等天然成分的需求,特别是在营养补充剂和增强免疫力的产品中。此外,几丁聚醣在创伤治疗和药物传输等健康相关应用中的使用正在增加,其抗菌特性也增加了需求。整体而言,这场大流行凸显了永续自然解决方案的重要性,长远来看有利于市场。
预计食品级细分市场在预测期内将是最大的
由于其天然、安全和多功能的特性,食品级市场预计是最大的市场。随着消费者健康意识的增强,食品级几丁聚醣越来越多地用作脂肪替代品、防腐剂和营养补充剂,特别是在减重产品中。其结合脂肪和降低胆固醇水平的能力进一步增加了几丁聚醣在机能性食品中的受欢迎程度。此外,食品加工中对天然和永续原料的日益偏好正在支持全球食品产业越来越多地采用食品级几丁聚醣。
预计农业部门在预测期内复合年增长率最高
由于农业具有天然生物杀虫、促进植物生长和土壤肥沃的特性,预计在预测期内复合年增长率最高。几丁聚醣用于保护作物免受真菌疾病、提高作物产量并刺激植物生长,使其成为化学农药的环保替代品。随着永续农业实践的发展和环境法规的收紧,几丁聚醣在有机农业和害虫防治中的作用变得越来越重要。由于几丁聚醣具有高度生物分解性和安全性,因此受到具有环保意识的农民的青睐,并且越来越多地应用于农业领域。
由于食品、医药和农业领域对天然和永续产品的需求不断增长,预计亚太地区在预测期内将占据最大的市场占有率。该地区渔业发达,是甲壳素的稳定来源,甲壳素是生产几丁聚醣的主要原料。人们对体重管理和降低胆固醇等健康益处的认识不断提高,也推动了市场的成长。此外,对生态友善有机农业方法的日益关注以及支持永续农业投入的政府法规也推动了该地区几丁聚醣的采用。
预计北美地区在预测期内的复合年增长率最高。几丁聚醣因其降低胆固醇和脂肪结合特性而广泛用于体重管理补充剂、机能性食品和药品。此外,对环境永续性的日益关注以及向环保包装和农业实践的转变正在推动几丁聚醣的日益普及。北美市场也受惠于蓬勃的研发活动,有助于几丁聚醣在食品加工和生物医学等各行业的创新应用。
According to Stratistics MRC, the Global Chitosan Market is accounted for $15.89 billion in 2024 and is expected to reach $53.20 billion by 2030 growing at a CAGR of 22.3% during the forecast period. Chitosan is a natural biopolymer derived from chitin, which is found in the shells of crustaceans like shrimp and crabs. It is a white, odourless, and biodegradable substance commonly used in various industries, including food, pharmaceuticals, agriculture, and cosmetics. Chitosan is valued for its ability to act as a fat binder, antimicrobial agent, and natural preservative. Due to its biocompatibility, it is widely used in medical applications, such as wound healing and drug delivery systems.
According to The National Fisheries Development Board, in India, total fish production during 2020 was estimated to be 12.60 million metric tons, of which nearly 65% was from the inland sector and about 50% of the total production was from culture fisheries, constituting about 6.3% of the global fish production.
Increasing use in food and beverage industry
Chitosan is valued for its natural preservative properties, helping extend shelf life and maintain food freshness without the need for synthetic chemicals. Additionally, it serves as a fat substitute in low-calorie, fat-free food items, satisfying the increased demand from consumers for healthier options. Furthermore, chitosan has been used into functional foods and nutritional supplements due to its capacity to bind fats and aid in weight management. The use of chitosan in food packaging and formulations is developing dramatically due to consumer preferences for natural, sustainable ingredients and the increased emphasis on health and wellness.
High production costs
The extraction of chitosan from crustacean shells requires a complex process involving demineralization, deacetylation, and purification, which increases production expenses. Additionally, the need for specialized equipment and technology to ensure quality and consistency adds to the cost. The reliance on raw materials, such as shrimp and crab shells, can also create supply chain challenges, further driving up prices. These high production costs make chitosan products more expensive compared to synthetic alternatives, limiting its market penetration in cost-sensitive applications, particularly in industries like food, packaging, and pharmaceuticals.
Rising applications in pharmaceuticals
Chitosan is increasingly used in the pharmaceutical industry due to its biocompatibility, biodegradability, and non-toxic nature. It plays a crucial role in drug delivery systems, particularly in controlled-release formulations, helping to improve the bioavailability of drugs. Additionally, chitosan is utilized in wound healing products, as it accelerates tissue regeneration and has antimicrobial properties. Its ability to bind fat and lower cholesterol also makes it a key ingredient in weight management supplements. As the demand for natural, effective, and sustainable solutions in pharmaceuticals rises, chitosan's versatility is expanding its applications in this sector.
Lack of consumer awareness
Lack of customer knowledge on the uses and advantages of chitosan is a major obstacle in the industry. Despite chitosan's extensive use in sectors like food, medicine, and agriculture, many consumers are not aware of its potential health advantages, which include lowering cholesterol, helping people lose weight, and acting as a natural preservative. Its adoption is restricted by this ignorance, especially in developing nations where consumers might not be aware of its applications in functional foods or nutritional supplements. To increase its market presence and stimulate growth, chitosan must educate customers about its benefits, including its environmental advantages and its adaptability in a variety of applications.
Covid-19 Impact
The COVID-19 pandemic had a mixed impact on the chitosan market. On one hand, the disruption in global supply chains affected the availability of raw materials, leading to delays in production and higher costs. On the other hand, the increased focus on health and wellness during the pandemic boosted the demand for natural ingredients like chitosan, particularly in dietary supplements and immune-boosting products. Additionally, the growing use of chitosan in health-related applications, such as wound healing and drug delivery, saw an uptick due to its antimicrobial properties. Overall, the pandemic highlighted the importance of sustainable, natural solutions, benefiting the market in the long term.
The food grade segment is expected to be the largest during the forecast period
The food grade segment is estimated to be the largest, driven by its natural, safe, and versatile properties. As consumers become more health-conscious, food-grade chitosan is increasingly used as a fat replacer, preservative, and dietary supplement, especially in weight loss products. Its ability to bind fats and reduce cholesterol levels further boosts its popularity in functional foods. Additionally, the rising preference for natural and sustainable ingredients in food processing supports the growing adoption of food-grade chitosan across the global food industry.
The agriculture segment is expected to have the highest CAGR during the forecast period
The agriculture segment is anticipated to witness the highest CAGR during the forecast period, due to its natural biopesticide, plant growth-promoting and soil-enhancing properties. Chitosan is used to protect crops from fungal diseases, improve crop yield, and stimulate plant growth, making it an eco-friendly alternative to chemical pesticides. As sustainable farming practices gain momentum and environmental regulations tighten, chitosan's role in organic farming and pest management becomes increasingly important. Its biodegradability and safety make it a preferred option for eco-conscious farmers, driving its adoption in the agricultural sector.
Asia Pacific is expected to have the largest market share during the forecast period due to growing demand for natural and sustainable products in food, pharmaceuticals, and agriculture. The region's large seafood industry provides a steady supply of chitin, a key raw material for chitosan production. Increasing awareness of health benefits, such as weight management and cholesterol reduction, also fuels market growth. Additionally, the rising focus on eco-friendly and organic farming practices, along with government regulations supporting sustainable agricultural inputs, drives the adoption of chitosan in the region.
During the forecast period, the North America region is anticipated to register the highest CAGR. Chitosan is widely used in weight management supplements, functional foods, and pharmaceuticals due to its cholesterol-lowering and fat-binding properties. Furthermore, the increasing focus on environmental sustainability and the transition to eco-friendly packaging and farming methods is driving greater adoption of chitosan. The North American market also benefits from robust research and development activities, contributing to innovative chitosan applications in various industries, including food processing and biomedicine.
Key players in the market
Some of the key players profiled in the Chitosan Market include KitoZyme SA, Chitosan International, GTC Bio Corporation, Advanced Biopolymers, Primex EHF, Shanghai Jinchang Pharmaceutical Co., Ltd., Green Chem, Heppe Medical Chitosan GmbH, Wako Chemicals USA, Inc., Merit Biotechnology Co., Ltd., Agratech, Taizhou Fuguo Biological Technology Co., Ltd., Tidal Vision, FMC Corporation, Nytt Biotech, Kraton Polymers, PT Biotech Surindo, ChitoTech, Jiangsu Nanjing G & D Pharmaceutical Co., and Shandong Jincheng Biotechnology Co., Ltd.
In June 2024, KitoZyme has partnered with DPH Biologicals, a Belgium-based manufacturer of pharmaceutical-grade fungal chitosan, to develop and commercialize the first sustainably-sourced chitosan seed treatment technology for U.S. growers.
In March 2022, MERIT CRO, Inc., a global clinical trial endpoint service provider focusing on the ophthalmic, respiratory, and oncology therapeutic areas, today announced the launch of its redesigned website.
According to Stratistics MRC, the Global Chitosan Market is accounted for $15.89 billion in 2024 and is expected to reach $53.20 billion by 2030 growing at a CAGR of 22.3% during the forecast period. Chitosan is a natural biopolymer derived from chitin, which is found in the shells of crustaceans like shrimp and crabs. It is a white, odourless, and biodegradable substance commonly used in various industries, including food, pharmaceuticals, agriculture, and cosmetics. Chitosan is valued for its ability to act as a fat binder, antimicrobial agent, and natural preservative. Due to its biocompatibility, it is widely used in medical applications, such as wound healing and drug delivery systems.
According to The National Fisheries Development Board, in India, total fish production during 2020 was estimated to be 12.60 million metric tons, of which nearly 65% was from the inland sector and about 50% of the total production was from culture fisheries, constituting about 6.3% of the global fish production.
Increasing use in food and beverage industry
Chitosan is valued for its natural preservative properties, helping extend shelf life and maintain food freshness without the need for synthetic chemicals. Additionally, it serves as a fat substitute in low-calorie, fat-free food items, satisfying the increased demand from consumers for healthier options. Furthermore, chitosan has been used into functional foods and nutritional supplements due to its capacity to bind fats and aid in weight management. The use of chitosan in food packaging and formulations is developing dramatically due to consumer preferences for natural, sustainable ingredients and the increased emphasis on health and wellness.
High production costs
The extraction of chitosan from crustacean shells requires a complex process involving demineralization, deacetylation, and purification, which increases production expenses. Additionally, the need for specialized equipment and technology to ensure quality and consistency adds to the cost. The reliance on raw materials, such as shrimp and crab shells, can also create supply chain challenges, further driving up prices. These high production costs make chitosan products more expensive compared to synthetic alternatives, limiting its market penetration in cost-sensitive applications, particularly in industries like food, packaging, and pharmaceuticals.
Rising applications in pharmaceuticals
Chitosan is increasingly used in the pharmaceutical industry due to its biocompatibility, biodegradability, and non-toxic nature. It plays a crucial role in drug delivery systems, particularly in controlled-release formulations, helping to improve the bioavailability of drugs. Additionally, chitosan is utilized in wound healing products, as it accelerates tissue regeneration and has antimicrobial properties. Its ability to bind fat and lower cholesterol also makes it a key ingredient in weight management supplements. As the demand for natural, effective, and sustainable solutions in pharmaceuticals rises, chitosan's versatility is expanding its applications in this sector.
Lack of consumer awareness
Lack of customer knowledge on the uses and advantages of chitosan is a major obstacle in the industry. Despite chitosan's extensive use in sectors like food, medicine, and agriculture, many consumers are not aware of its potential health advantages, which include lowering cholesterol, helping people lose weight, and acting as a natural preservative. Its adoption is restricted by this ignorance, especially in developing nations where consumers might not be aware of its applications in functional foods or nutritional supplements. To increase its market presence and stimulate growth, chitosan must educate customers about its benefits, including its environmental advantages and its adaptability in a variety of applications.
Covid-19 Impact
The COVID-19 pandemic had a mixed impact on the chitosan market. On one hand, the disruption in global supply chains affected the availability of raw materials, leading to delays in production and higher costs. On the other hand, the increased focus on health and wellness during the pandemic boosted the demand for natural ingredients like chitosan, particularly in dietary supplements and immune-boosting products. Additionally, the growing use of chitosan in health-related applications, such as wound healing and drug delivery, saw an uptick due to its antimicrobial properties. Overall, the pandemic highlighted the importance of sustainable, natural solutions, benefiting the market in the long term.
The food grade segment is expected to be the largest during the forecast period
The food grade segment is estimated to be the largest, driven by its natural, safe, and versatile properties. As consumers become more health-conscious, food-grade chitosan is increasingly used as a fat replacer, preservative, and dietary supplement, especially in weight loss products. Its ability to bind fats and reduce cholesterol levels further boosts its popularity in functional foods. Additionally, the rising preference for natural and sustainable ingredients in food processing supports the growing adoption of food-grade chitosan across the global food industry.
The agriculture segment is expected to have the highest CAGR during the forecast period
The agriculture segment is anticipated to witness the highest CAGR during the forecast period, due to its natural biopesticide, plant growth-promoting and soil-enhancing properties. Chitosan is used to protect crops from fungal diseases, improve crop yield, and stimulate plant growth, making it an eco-friendly alternative to chemical pesticides. As sustainable farming practices gain momentum and environmental regulations tighten, chitosan's role in organic farming and pest management becomes increasingly important. Its biodegradability and safety make it a preferred option for eco-conscious farmers, driving its adoption in the agricultural sector.
Asia Pacific is expected to have the largest market share during the forecast period due to growing demand for natural and sustainable products in food, pharmaceuticals, and agriculture. The region's large seafood industry provides a steady supply of chitin, a key raw material for chitosan production. Increasing awareness of health benefits, such as weight management and cholesterol reduction, also fuels market growth. Additionally, the rising focus on eco-friendly and organic farming practices, along with government regulations supporting sustainable agricultural inputs, drives the adoption of chitosan in the region.
During the forecast period, the North America region is anticipated to register the highest CAGR. Chitosan is widely used in weight management supplements, functional foods, and pharmaceuticals due to its cholesterol-lowering and fat-binding properties. Furthermore, the increasing focus on environmental sustainability and the transition to eco-friendly packaging and farming methods is driving greater adoption of chitosan. The North American market also benefits from robust research and development activities, contributing to innovative chitosan applications in various industries, including food processing and biomedicine.
Key players in the market
Some of the key players profiled in the Chitosan Market include KitoZyme SA, Chitosan International, GTC Bio Corporation, Advanced Biopolymers, Primex EHF, Shanghai Jinchang Pharmaceutical Co., Ltd., Green Chem, Heppe Medical Chitosan GmbH, Wako Chemicals USA, Inc., Merit Biotechnology Co., Ltd., Agratech, Taizhou Fuguo Biological Technology Co., Ltd., Tidal Vision, FMC Corporation, Nytt Biotech, Kraton Polymers, PT Biotech Surindo, ChitoTech, Jiangsu Nanjing G & D Pharmaceutical Co., and Shandong Jincheng Biotechnology Co., Ltd.
In June 2024, KitoZyme has partnered with DPH Biologicals, a Belgium-based manufacturer of pharmaceutical-grade fungal chitosan, to develop and commercialize the first sustainably-sourced chitosan seed treatment technology for U.S. growers.
In March 2022, MERIT CRO, Inc., a global clinical trial endpoint service provider focusing on the ophthalmic, respiratory, and oncology therapeutic areas, today announced the launch of its redesigned website.